ABSORICA LD

Approval Id: cb69389befafa739
Drug Approval Canada Name: ABSORICA LD
Product Name: ABSORICA LD
Status: Marketed
Status Date: 2023-09-26
Original Market Date: 2023-09-26
Din: 02539055
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 84:92.00
Atc Original: D10BA01 ISOTRETINOIN
Atc Name: d 10 ba 01
Aig Number: 0115751007
Company Name: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Company Address: Sun House, Plot 201 B/1, Western Express Highway, Goregaon (E), Mumbai, Maharashtra, India, 400063
Company Detail Path: /organization/sun-pharmaceutical-industries-limited

ISOTRETINOIN

16 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

cb69389befafa739

Type

Standard